newsfilter
← Latest News
PR Newswire·

Palatin Technologies Announces Pricing of up to $23 Million Public Offering

Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based...